CustomerInsights.AI Named to the 2026 Deloitte Technology Fast 500™ List of North America's Fastest-Growing Technology Companies
PR Newswire
SCOTTSDALE, Ariz., Nov. 19, 2026
CustomerInsights.AI joins 2026 Deloitte Technology Fast 500™, reflecting rapid growth as Life Sciences organizations embrace Technology-Led Analytics and Agentic AI.
SCOTTSDALE, Ariz., Nov. 19, 2026 /PRNewswire/ -- CustomerInsights.AI (CIAI) today announced that it has been named to the 2026 Deloitte Technology Fast 500™, a ranking of North America's fastest-growing technology companies. The recognition reflects CIAI's sustained growth trajectory as Pharmaceutical and Biotech organizations increasingly turn to CIAI to modernize their commercial analytics with AI.
For more than 30 years, the Deloitte Technology Fast 500™ has recognized companies that are redefining how the world lives, works, and plays, from established innovators to emerging disruptors.
CIAI's innovation success traces back to a problem known well in the Life Sciences industry where all support models (internal & external) are constructed on the prefix that 80% is driven by people and 20% by technology. CIAI inverted this model by developing solutions and services from the ground up that is 80% technology and 20% people. This is fundamentally redefining everything for our clients – ways of working, definition of success, ROI etc.
CIAI successfully achieved this outcome through its analytics accelerators ciPARTHENON® and ciATHENA®. While ciPARTHENON® consolidates and addresses every day organizational needs, ciATHENA® addresses what comes next. Life Sciences organizations now run a growing mix of AI models and specialized agents, often operating with different context, definitions, and controls. Rather than adding one more agent, ciATHENA® acts as the commercial command center they all work from, giving native, client-built, and third-party agents shared pharma context and a single governance standard.
Both solutions within the ecosystem cover six core commercial functions, including Value & Access, Patient Journey & Treatment Insights, Brand Performance & Growth Analytics, Marketing & Customer Engagement, Commercial Excellence & Sales Operations, and Data Strategy, Management & Governance. Uniquely, CIAI works on an outcomes-based model, tying its engagement to the commercial results clients achieve without billing by license or staff hours.
"Being named to the Deloitte Technology Fast 500™ is a powerful validation of what our clients and our teams have built together. Life Sciences companies are under pressure to turn data into confident action faster than ever, and our growth reflects the trust they place in us to deliver real outcomes, not just technology," said Abhay Jajoo, Founder & CEO of CIAI. "This recognition belongs to every member of the CIAI team whose pharmaceutical expertise and commitment to impact drive our clients' success."
"Growth only matters when it is built on delivering real value. Our outcomes-based model, deep Life Sciences expertise, and platforms such as ciPARTHENON® and ciATHENA® have enabled us to scale alongside our clients and their ambitions. We set out to be a disruptor in this industry, challenging conventional approaches and creating better ways to solve complex problems. We're proud to be recognized on this list, but even more excited about what we will build next for the Life Sciences industry," said Robin Varghese, Co-Founder & COO of CIAI.
About Deloitte Technology Fast 500™
The Deloitte Technology Fast 500™ recognizes North America's fastest-growing technology companies. For more than 30 years, the program has honored technology pioneers transforming how we live, work, and play, from established innovators to emerging disruptors. Winners are drawn from across the technology landscape, and the majority are privately held companies. For more information, visit Deloitte.com.
View the full 2026 Deloitte Technology Fast 500™ rankings
About CustomerInsights.AI
CustomerInsights.AI is a Platform-Led Analytics-as-a-Service company built exclusively for the Life Sciences industry. Founded in 2018 by Pharmaceutical and Analytics leaders, the company was built on the belief that AI should become a core operational capability rather than a standalone innovation initiative. CIAI has pioneered an Outcomes model that combines technology, deep domain expertise, and execution to deliver Commercial Intelligence as measurable outcomes for Life Sciences organizations.
Its flagship platforms, ciPARTHENON® and ciATHENA®, help Pharmaceutical and Biotech organizations modernize their analytics ecosystems, reduce operational complexity, and improve commercial decision-making through AI-powered intelligence.
CIAI serves clients ranging from emerging Biotech companies to some of the world's leading Pharmaceutical organizations through teams across North America and India.
View original content to download multimedia:https://www.prnewswire.com/news-releases/customerinsightsai-named-to-the-2026-deloitte-technology-fast-500-list-of-north-americas-fastest-growing-technology-companies-302945661.html
SOURCE CustomerInsights.AI

